Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Mechanistic Basis of Antimicrobial Actions of Silver Nanoparticles.

Dakal TC, Kumar A, Majumdar RS, Yadav V.

Front Microbiol. 2016 Nov 16;7:1831. Review.

2.
3.

Towards Rational Design of a Toxoid Vaccine against the Heat-Stable Toxin of Escherichia coli.

Taxt AM, Diaz Y, Aasland R, Clements JD, Nataro JP, Sommerfelt H, Puntervoll P.

Infect Immun. 2016 Mar 24;84(4):1239-49. doi: 10.1128/IAI.01225-15.

4.

Characterization of Mucosal Immune Responses to Enterotoxigenic Escherichia coli Vaccine Antigens in a Human Challenge Model: Response Profiles after Primary Infection and Homologous Rechallenge with Strain H10407.

Chakraborty S, Harro C, DeNearing B, Ram M, Feller A, Cage A, Bauers N, Bourgeois AL, Walker R, Sack DA.

Clin Vaccine Immunol. 2015 Nov 18;23(1):55-64. doi: 10.1128/CVI.00617-15.

5.

Relationship between heat-labile enterotoxin secretion capacity and virulence in wild type porcine-origin enterotoxigenic Escherichia coli strains.

Wijemanne P, Xing J, Berberov EM, Marx DB, Francis DH, Moxley RA.

PLoS One. 2015 Mar 13;10(3):e0117663. doi: 10.1371/journal.pone.0117663.

6.

Antibacterial activity of silver and zinc nanoparticles against Vibrio cholerae and enterotoxic Escherichia coli.

Salem W, Leitner DR, Zingl FG, Schratter G, Prassl R, Goessler W, Reidl J, Schild S.

Int J Med Microbiol. 2015 Jan;305(1):85-95. doi: 10.1016/j.ijmm.2014.11.005.

7.
8.

Toxins and virulence factors of enterotoxigenic Escherichia coli associated with strains isolated from indigenous children and international visitors to a rural community in Guatemala.

Torres OR, González W, Lemus O, Pratdesaba RA, Matute JA, Wiklund G, Sack DA, Bourgeois AL, Svennerholm AM.

Epidemiol Infect. 2015 Jun;143(8):1662-71. doi: 10.1017/S0950268814002295.

9.

Experimental infection of healthy volunteers with enterotoxigenic Escherichia coli wild-type strain TW10598 in a hospital ward.

Skrede S, Steinsland H, Sommerfelt H, Aase A, Brandtzaeg P, Langeland N, Cox RJ, Saevik M, Wallevik M, Skutlaberg DH, Tellevik MG, Sack DA, Nataro JP, Guttormsen AB.

BMC Infect Dis. 2014 Sep 4;14:482. doi: 10.1186/1471-2334-14-482.

10.

Phenotypic and genotypic characterization of enterotoxigenic Escherichia coli clinical isolates from northern Colombia, South America.

Guerra JA, Romero-Herazo YC, Arzuza O, Gómez-Duarte OG.

Biomed Res Int. 2014;2014:236260. doi: 10.1155/2014/236260.

11.

Molecular characterization of Enterotoxigenic Escherichia coli strains isolated from diarrheal patients in Korea during 2003-2011.

Oh KH, Kim DW, Jung SM, Cho SH.

PLoS One. 2014 May 19;9(5):e96896. doi: 10.1371/journal.pone.0096896.

12.

Characterization of immunological cross-reactivity between enterotoxigenic Escherichia coli heat-stable toxin and human guanylin and uroguanylin.

Taxt AM, Diaz Y, Bacle A, Grauffel C, Reuter N, Aasland R, Sommerfelt H, Puntervoll P.

Infect Immun. 2014 Jul;82(7):2913-22. doi: 10.1128/IAI.01749-14.

13.

Vaccines for the prevention of diarrhea due to cholera, shigella, ETEC and rotavirus.

Das JK, Tripathi A, Ali A, Hassan A, Dojosoeandy C, Bhutta ZA.

BMC Public Health. 2013;13 Suppl 3:S11. doi: 10.1186/1471-2458-13-S3-S11. Review.

14.

Recent advances in understanding enteric pathogenic Escherichia coli.

Croxen MA, Law RJ, Scholz R, Keeney KM, Wlodarska M, Finlay BB.

Clin Microbiol Rev. 2013 Oct;26(4):822-80. doi: 10.1128/CMR.00022-13. Review.

15.

Safety and immunogenicity of a single oral dose of recombinant double mutant heat-labile toxin derived from enterotoxigenic Escherichia coli.

El-Kamary SS, Cohen MB, Bourgeois AL, Van De Verg L, Bauers N, Reymann M, Pasetti MF, Chen WH.

Clin Vaccine Immunol. 2013 Nov;20(11):1764-70. doi: 10.1128/CVI.00464-13. Erratum in: Clin Vaccine Immunol. 2014 Apr;21(4):602.

16.

Genotypic characterization of enterotoxigenic Escherichia coli strains causing traveler's diarrhea.

Rivera FP, Medina AM, Aldasoro E, Sangil A, Gascon J, Ochoa TJ, Vila J, Ruiz J.

J Clin Microbiol. 2013 Feb;51(2):633-5. doi: 10.1128/JCM.02572-12.

17.

Transcriptional modulation of enterotoxigenic Escherichia coli virulence genes in response to epithelial cell interactions.

Kansal R, Rasko DA, Sahl JW, Munson GP, Roy K, Luo Q, Sheikh A, Kuhne KJ, Fleckenstein JM.

Infect Immun. 2013 Jan;81(1):259-70. doi: 10.1128/IAI.00919-12.

19.
20.

Antibody against recombinant heat labile enterotoxin B subunit (rLTB) could block LT binding to ganglioside M1 receptor.

Salimian J, Salmanian A, Khalesi R, Mohseni M, Moazzeni S.

Iran J Microbiol. 2010 Sep;2(3):120-7.

Supplemental Content

Support Center